Biotech Values

[mcbio]

So here's a challenge for you and the Board - come up with a hedged HCV portfolio. Something along the lines of 5 stocks long and 5 stocks short.

I agree pretty much entirely with Dew's picks (#msg-63571059) though I haven't followed Debiopharm closely enough to have an informed opinion on them. Also, while I don't exactly have a glowing opinion of INHX, they are pretty much the only HCV nuke game left in town aside from VRUS after IDIX's serious problems. If a big pharma that needs an HCV nuke isn't willing to pay the steep price that VRUS is asking (and they can afford to be very stingy given their cash hoard and great data to date), they could come calling on INHX at some point should their HCV nuke continue to progress in the clinic. You could also look at it as only a few companies at most will be involved with the VRUS nukes so any others could look squarely at INHX if they need an HCV nuke. So, I probably wouldn't have the courage to short INHX, though I'm certainly not ready to consider a long position at this point either.